from Reuters: Health News https://ift.tt/2SA1IHS
Top Bristol-Myers shareholder comes out against $74 billion Celgene deal
Bristol-Myers Squibb Co's top shareholder Wellington Management said on Wednesday it does not support the U.S. drugmaker's $74 billion deal to buy biotech Celgene Corp, imperiling what would be the largest pharmaceutical acquisition of all time.
from Reuters: Health News https://ift.tt/2SA1IHS
from Reuters: Health News https://ift.tt/2SA1IHS
Subscribe to:
Post Comments (Atom)
-
The German cabinet will hold a secret session on Wednesday to discuss safeguard measures regarding the possible participation of China's...
-
Stocks poised for another day of gains Equity markets look to add to the gains from the prior session as investor concerns about the fu...
-
By LIAM STACK from NYT Magazine https://ift.tt/2FNPp6k
No comments:
Post a Comment